CD8A and neoplasm: As in non-tumor bearing mice, administration of IL-15SA/IL-15RαSu-Fc to mice induced the greatest effect on NK cells (3.5 fold, p < 0.001), followed by a significant increase in CD8+ and CD4+ T-cells (Figure 6A and 6B).